USE OF A PROGESTERONE ANTAGONIST AND OF A GESTAGEN FOR THE TREATMENT OF ENDOMETRIOSIS OR LEIOMYOMATA UTERI
OA: closed
AI-generated summary
This patent describes a sequential oral treatment combining a competitive progesterone antagonist and a gestagen for use as a medicament in treating endometriosis or leiomyomata uteri.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The present invention concerns the use of a product containing in combination individual dosage units of a competitive progesterone antagonist and individual dosage units of a gestagen to be sequentially orally administrated (the competitive progesterone antagonist being present in each individual dosage unit in quantities not capable of inducing miscarriage) to produce a medicament for use in the treatment of endometriosis or leiomyomata uteri.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-06T06:10:23.601157+00:00